Skip to main content

Advertisement

ADVERTISEMENT

Recovery

News
06/14/2023
Only 1 in 4 residential addiction treatment facilities caring for adolescents in the US offers buprenorphine, with just 1 in 8 offering buprenorphine for ongoing treatment, according to an Oregon Health & Science University study released on...
Only 1 in 4 residential addiction treatment facilities caring for adolescents in the US offers buprenorphine, with just 1 in 8 offering buprenorphine for ongoing treatment, according to an Oregon Health & Science University study released on...
Only 1 in 4 residential...
06/14/2023
Addiction Professional
Drew Dutton, MEd, MBA, LPC-S, LCDC, ACPS
News
06/05/2023
Drew Dutton, MEd, MBA, LPC-S, LCDC, ACPS, the president and CEO of Phoenix House Texas, who presented at the West Coast Symposium on Saturday, explains why addiction treatment modalities that work for adults may not have the same efficacy...
Drew Dutton, MEd, MBA, LPC-S, LCDC, ACPS, the president and CEO of Phoenix House Texas, who presented at the West Coast Symposium on Saturday, explains why addiction treatment modalities that work for adults may not have the same efficacy...
Drew Dutton, MEd, MBA, LPC-S,...
06/05/2023
Addiction Professional
John de Miranda, EdM, CRC
News
06/02/2023
West Coast Symposium presenter John de Miranda, EdM, CRC, explains why 2022 was a breakout year for the integration of harm reduction practices within the addiction treatment field, but significant work remains.
West Coast Symposium presenter John de Miranda, EdM, CRC, explains why 2022 was a breakout year for the integration of harm reduction practices within the addiction treatment field, but significant work remains.
West Coast Symposium presenter...
06/02/2023
Addiction Professional
News
05/24/2023
One day after approving a new opioid overdose reversal nasal spray product, the US Food and Drug Administration approved Brixadi, a subcutaneous buprenorphine treatment option available in weekly and monthly formulations.
One day after approving a new opioid overdose reversal nasal spray product, the US Food and Drug Administration approved Brixadi, a subcutaneous buprenorphine treatment option available in weekly and monthly formulations.
One day after approving a new...
05/24/2023
Addiction Professional
News
05/23/2023
The US Food and Drug Administration has approved Opvee, a new opioid overdose reversal nasal spray for patients at least 12 years of age. The medication was developed by a pharmaceutical company within the Indivior portfolio.
The US Food and Drug Administration has approved Opvee, a new opioid overdose reversal nasal spray for patients at least 12 years of age. The medication was developed by a pharmaceutical company within the Indivior portfolio.
The US Food and Drug...
05/23/2023
Addiction Professional
News
05/16/2023
A study by researchers at Harvard University and Dartmouth College shows a discrepancy in the rates in which various populations receive medications for opioid use disorder despite making a similar number of visits to healthcare providers.
A study by researchers at Harvard University and Dartmouth College shows a discrepancy in the rates in which various populations receive medications for opioid use disorder despite making a similar number of visits to healthcare providers.
A study by researchers at...
05/16/2023
Addiction Professional
Scott Weiner, MD, MPH, Michelle Hendricks, PhD, and Sanae El Ibrahimi, PhD, MPH
News
05/02/2023
Rx Summit presenters Scott Weiner, MD, MPH, Michelle Hendricks, PhD, and Sanae El Ibrahimi, PhD, MPH, explain how merging public data sets can provide deeper insights into addiction and ways interventions can be improved.
Rx Summit presenters Scott Weiner, MD, MPH, Michelle Hendricks, PhD, and Sanae El Ibrahimi, PhD, MPH, explain how merging public data sets can provide deeper insights into addiction and ways interventions can be improved.
Rx Summit presenters Scott...
05/02/2023
Psychiatry & Behavioral Health
News
04/27/2023
Engaging in regular physical activity has been linked with reduced illicit substance and alcohol use among individuals in recovery, according to review of 43 past studies published this week.
Engaging in regular physical activity has been linked with reduced illicit substance and alcohol use among individuals in recovery, according to review of 43 past studies published this week.
Engaging in regular physical...
04/27/2023
Addiction Professional
News
04/24/2023
Rx Summit presenters Kelley McNichols, PhD, LPC, NCC, CADC, CCDP, CCTP, and Mike Krafick, CRS, CRSS, discuss the value of intercept initiatives that help individuals in underserved areas.
Rx Summit presenters Kelley McNichols, PhD, LPC, NCC, CADC, CCDP, CCTP, and Mike Krafick, CRS, CRSS, discuss the value of intercept initiatives that help individuals in underserved areas.
Rx Summit presenters Kelley...
04/24/2023
Psychiatry & Behavioral Health
News
04/13/2023
For the first time in the 12-year history of the Rx and Illicit Drug Summit, the topic of overdose prevention centers took center stage on Thursday morning, with stakeholders involved with OPCs in the US convening for a panel.
For the first time in the 12-year history of the Rx and Illicit Drug Summit, the topic of overdose prevention centers took center stage on Thursday morning, with stakeholders involved with OPCs in the US convening for a panel.
For the first time in the...
04/13/2023
Addiction Professional

Advertisement

Advertisement